Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002025608 | SCV002293632 | uncertain significance | Hereditary spastic paraplegia 11 | 2021-08-22 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. This variant has not been reported in the literature in individuals affected with SPG11-related conditions. This variant is present in population databases (rs771186100, ExAC 0.001%). This sequence change replaces proline with alanine at codon 1594 of the SPG11 protein (p.Pro1594Ala). The proline residue is highly conserved and there is a small physicochemical difference between proline and alanine. |